Latest News

Recent Topics

Entrepreneurial Spirit

The work biomedical engineers perform in the laboratory will, ideally, improve patients' lives. A new company that began in the lab at Rowan University is on the path to doing just that.(pg.26)

Alzheimer's therapeutic development

CONDUCTink is a biotechnology company that delivers perfusable in-vitro models for preclinical Alzheimer's therapeutic discovery. Founded in 2023 by Louis Paone and Peter Galie, Ph.D., an associate professor of biomedical engineering, the company developed a platform to screen drugs related to Alzheimer's disease with the goal of ultimately replacing animal models.

CSIT Awards CONDUCTink Seed Grant for Alzheimer’s Drug Discovery Model

Our Progress

November 2022
Spinal Cord Discovery

The Galie lab at Rowan University completes the 4-week NSF Northeast Regional I-Corps program conducting customer discovery for spinal cord injury therapeutics

May 2023
Founded & Started

CONDUCTink is founded by Peter Galie, Ph.D. and Louis S. Paone spinning out of Rowan Universities department of Biomedical Engineering

October 2023
Publication

Louis S. Paone's manuscript “A 3D-printed blood-brain barrier model with tunable topology and cell-matrix interactions” is published in Biofabrication

November 2023
In The Field

CONDUCTink completes the 7-week NSF National I-Corp program conducting over +100 in-person customer discovery interviews across the country for Alzheimer's drug discovery

January 2024
Partners

A strategic partnership with Vitroscope is launched

March 2024
Publication

Louis S. Paones manuscript “Effects of Drag-Reducing Polymers on Hemodynamics and Whole Blood-Endothelial Interactions in 3D-Printed Vascular Topologies” in ACS Applied Materials & Interfaces

April 2024
Partners

A strategic partnership with Etaluma, Inc. is launched